Lilly (Eli) (LLY) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification, pre-planned 10b5-1 sales) and isn't treated as a signal here.
Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.- Next earnings expected around Feb 3, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Sale Anat Hakim, Evp, Gc & Secretary sold 5,000 shares at $1,402.52 ($7.0M).
- Trade date
- Nov 2, 2026
- Disclosed to the SEC
- Nov 3, 2026
- Type
- Pre-planned sale, 10b5-1 (code S)
Read the original SEC filing ↗All LLY insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
LLY insider transactions (Form 4)
Open-market purchases and sales. 142 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Nov 3SEC | Anat HakimEvp, Gc & Secretary | Sell Plan | 5,0004,137 held (−55%) | $1,402.52 | $7.0M | -3.5% | — |
| Aug 18SEC | Patrik JonssonPresident | Sell Plan | 6,50054,147 held (−11%) | $1,175.10 | $7.6M | +15.2% | — |
| Aug 11SEC | Donald A. ZakrowskiSvp, Finance, & Cao | Sell Plan | 2,0001,526 held (−57%) | $1,185.01 | $2.4M | +14.2% | — |
| Aug 10SEC | Anat HakimEvp, Gc & Secretary | Sell Plan | 5,00011,875 held (−30%) | $1,190.00 | $6.0M | +13.7% | — |
| Jun 11SEC | Ilya YuffaEvp&Pres, Lly Usa&Global Capab | Sell Plan | 2,50029,804 held (−8%) | $1,150.77 | $2.9M | +17.6% | — |
| May 7SEC | Lilly Endowment IncFormer 10% Shareholder | Sell | 13,62091,883,358 held (−0%) | $995.23 | $13.6M | +36.0% | — |
| May 7SEC | Lilly Endowment IncFormer 10% Shareholder | Sell | 2,20891,881,150 held (−0%) | $996.18 | $2.2M | +35.9% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 40,95692,023,036 held (−0%) | $1,103.31 | $45.2M | +22.7% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 34,43492,063,992 held (−0%) | $1,102.41 | $38.0M | +22.8% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 24,36291,977,632 held (−0%) | $1,105.46 | $26.9M | +22.4% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 21,04292,001,994 held (−0%) | $1,104.40 | $23.2M | +22.6% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 20,66892,098,426 held (−0%) | $1,101.42 | $22.8M | +22.9% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 20,44792,134,031 held (−0%) | $1,099.36 | $22.5M | +23.1% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 16,65091,947,281 held (−0%) | $1,107.37 | $18.4M | +22.2% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 14,93792,119,094 held (−0%) | $1,100.46 | $16.4M | +23.0% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 13,70191,963,931 held (−0%) | $1,106.42 | $15.2M | +22.3% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 13,24791,934,034 held (−0%) | $1,108.41 | $14.7M | +22.1% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 9,57392,154,478 held (−0%) | $1,098.55 | $10.5M | +23.2% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 9,05391,906,267 held (−0%) | $1,113.77 | $10.1M | +21.5% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 8,51391,925,521 held (−0%) | $1,109.32 | $9.4M | +22.0% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 7,68492,180,547 held (−0%) | $1,086.75 | $8.4M | +24.5% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 6,40892,164,051 held (−0%) | $1,097.41 | $7.0M | +23.3% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 4,65291,915,320 held (−0%) | $1,112.43 | $5.2M | +21.7% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 4,34291,901,925 held (−0%) | $1,114.37 | $4.8M | +21.5% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 3,57592,174,972 held (−0%) | $1,090.18 | $3.9M | +24.2% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 3,46491,922,057 held (−0%) | $1,110.37 | $3.8M | +21.9% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 2,73791,896,978 held (−0%) | $1,116.69 | $3.1M | +21.2% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 2,21091,899,715 held (−0%) | $1,115.76 | $2.5M | +21.3% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 2,08591,919,972 held (−0%) | $1,111.21 | $2.3M | +21.8% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 1,32292,171,354 held (−0%) | $1,093.58 | $1.4M | +23.8% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 1,22492,173,748 held (−0%) | $1,091.05 | $1.3M | +24.1% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 1,07292,172,676 held (−0%) | $1,092.56 | $1.2M | +23.9% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 1,07092,179,477 held (−0%) | $1,087.80 | $1.2M | +24.4% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 93092,178,547 held (−0%) | $1,088.97 | $1.0M | +24.3% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 89592,188,231 held (−0%) | $1,085.11 | $971K | +24.7% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 47592,170,459 held (−0%) | $1,095.74 | $520K | +23.5% | — |
| Jan 8SEC | Lilly Endowment Inc10% Owner | Sell | 42092,170,934 held (−0%) | $1,094.70 | $460K | +23.6% | — |
| Jan 6SEC | Lilly Endowment Inc10% Owner | Sell | 1,39092,189,126 held (−0%) | $1,085.01 | $1.5M | +24.7% | — |
| Dec 30SEC | Lilly Endowment Inc10% Owner | Sell | 3,59392,190,516 held (−0%) | $1,085.04 | $3.9M | +24.7% | — |
| Dec 29SEC | Lilly Endowment Inc10% Owner | Sell | 2,62992,194,109 held (−0%) | $1,085.17 | $2.9M | +24.7% | — |
| Dec 29SEC | Lilly Endowment Inc10% Owner | Sell | 24092,196,738 held (−0%) | $1,085.04 | $260K | +24.7% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 18,25492,299,689 held (−0%) | $1,092.06 | $19.9M | +23.9% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 11,85492,245,486 held (−0%) | $1,101.45 | $13.1M | +22.9% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 9,24992,198,318 held (−0%) | $1,109.45 | $10.3M | +22.0% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 9,05092,290,639 held (−0%) | $1,093.16 | $9.9M | +23.8% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 8,52792,257,340 held (−0%) | $1,100.34 | $9.4M | +23.0% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 7,79492,212,610 held (−0%) | $1,107.48 | $8.6M | +22.2% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 7,45692,238,030 held (−0%) | $1,102.35 | $8.2M | +22.8% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 6,54592,265,867 held (−0%) | $1,099.48 | $7.2M | +23.1% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 6,50892,336,650 held (−0%) | $1,086.94 | $7.1M | +24.5% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 6,27492,231,756 held (−0%) | $1,103.58 | $6.9M | +22.6% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 6,24692,284,393 held (−0%) | $1,094.03 | $6.8M | +23.7% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 5,92792,317,943 held (−0%) | $1,091.12 | $6.5M | +24.0% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 5,60492,343,158 held (−0%) | $1,086.07 | $6.1M | +24.6% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 5,58992,331,061 held (−0%) | $1,087.96 | $6.1M | +24.4% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 5,28492,325,777 held (−0%) | $1,088.91 | $5.8M | +24.3% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 5,19692,226,560 held (−0%) | $1,104.41 | $5.7M | +22.6% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 5,04392,207,567 held (−0%) | $1,108.71 | $5.6M | +22.1% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 4,63992,272,412 held (−0%) | $1,098.32 | $5.1M | +23.2% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 4,19892,277,051 held (−0%) | $1,097.44 | $4.6M | +23.3% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 3,66292,220,404 held (−0%) | $1,106.57 | $4.1M | +22.3% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 3,06992,348,762 held (−0%) | $1,084.70 | $3.3M | +24.8% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 2,49492,224,066 held (−0%) | $1,105.32 | $2.8M | +22.5% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 2,48192,357,190 held (−0%) | $1,073.73 | $2.7M | +26.1% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 2,08392,282,310 held (−0%) | $1,094.79 | $2.3M | +23.6% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 1,90792,323,870 held (−0%) | $1,089.85 | $2.1M | +24.2% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 1,60692,351,991 held (−0%) | $1,081.90 | $1.7M | +25.1% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 1,34092,196,978 held (−0%) | $1,110.53 | $1.5M | +21.9% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 1,26092,354,248 held (−0%) | $1,079.37 | $1.4M | +25.4% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 1,06192,281,249 held (−0%) | $1,096.33 | $1.2M | +23.5% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 88292,356,308 held (−0%) | $1,076.00 | $949K | +25.8% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 80092,355,508 held (−0%) | $1,077.99 | $862K | +25.6% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 65192,353,597 held (−0%) | $1,080.73 | $704K | +25.2% | — |
| Nov 26SEC | Lilly Endowment Inc10% Owner | Sell | 16092,351,831 held (−0%) | $1,082.93 | $173K | +25.0% | — |
| Nov 25SEC | Lilly Endowment Inc10% Owner | Sell | 120,01692,381,962 held (−0%) | $1,068.17 | $128M | +26.7% | — |
| Nov 25SEC | Lilly Endowment Inc10% Owner | Sell | 14,10592,367,857 held (−0%) | $1,069.48 | $15.1M | +26.6% | — |
| Nov 25SEC | Lilly Endowment Inc10% Owner | Sell | 2,95492,359,671 held (−0%) | $1,073.60 | $3.2M | +26.1% | — |
| Nov 25SEC | Lilly Endowment Inc10% Owner | Sell | 2,77892,365,079 held (−0%) | $1,070.35 | $3.0M | +26.5% | — |
| Nov 25SEC | Lilly Endowment Inc10% Owner | Sell | 1,71092,363,369 held (−0%) | $1,071.37 | $1.8M | +26.3% | — |
| Nov 25SEC | Lilly Endowment Inc10% Owner | Sell | 74492,362,625 held (−0%) | $1,072.78 | $798K | +26.2% | — |
| Nov 24SEC | Lilly Endowment Inc10% Owner | Sell | 23,91692,542,676 held (−0%) | $1,059.66 | $25.3M | +27.7% | — |
| Nov 24SEC | Lilly Endowment Inc10% Owner | Sell | 10,49292,524,602 held (−0%) | $1,061.56 | $11.1M | +27.5% | — |
| Nov 24SEC | Lilly Endowment Inc10% Owner | Sell | 9,87192,597,433 held (−0%) | $1,050.27 | $10.4M | +28.9% | — |
| Nov 24SEC | Lilly Endowment Inc10% Owner | Sell | 9,72992,566,592 held (−0%) | $1,058.46 | $10.3M | +27.9% | — |
| Nov 24SEC | Lilly Endowment Inc10% Owner | Sell | 9,05192,515,551 held (−0%) | $1,062.52 | $9.6M | +27.4% | — |
| Nov 24SEC | Lilly Endowment Inc10% Owner | Sell | 8,57692,506,975 held (−0%) | $1,063.57 | $9.1M | +27.3% | — |
| Nov 24SEC | Lilly Endowment Inc10% Owner | Sell | 7,58292,535,094 held (−0%) | $1,060.53 | $8.0M | +27.6% | — |
| Nov 24SEC | Lilly Endowment Inc10% Owner | Sell | 5,50692,591,927 held (−0%) | $1,051.48 | $5.8M | +28.7% | — |
| Nov 24SEC | Lilly Endowment Inc10% Owner | Sell | 5,06492,576,321 held (−0%) | $1,057.58 | $5.4M | +28.0% | — |
| Nov 24SEC | Lilly Endowment Inc10% Owner | Sell | 3,37892,503,597 held (−0%) | $1,064.43 | $3.6M | +27.2% | — |
| Nov 24SEC | Lilly Endowment Inc10% Owner | Sell | 2,88592,589,042 held (−0%) | $1,052.36 | $3.0M | +28.6% | — |
| Nov 24SEC | Lilly Endowment Inc10% Owner | Sell | 2,49592,582,931 held (−0%) | $1,055.45 | $2.6M | +28.2% | — |
| Nov 24SEC | Lilly Endowment Inc10% Owner | Sell | 1,98792,587,055 held (−0%) | $1,053.46 | $2.1M | +28.5% | — |
| Nov 24SEC | Lilly Endowment Inc10% Owner | Sell | 1,62992,585,426 held (−0%) | $1,054.42 | $1.7M | +28.4% | — |
| Nov 24SEC | Lilly Endowment Inc10% Owner | Sell | 1,54692,581,385 held (−0%) | $1,056.40 | $1.6M | +28.1% | — |
| Nov 24SEC | Lilly Endowment Inc10% Owner | Sell | 1,45992,502,138 held (−0%) | $1,065.57 | $1.6M | +27.0% | — |
| Nov 24SEC | Lilly Endowment Inc10% Owner | Sell | 16092,501,978 held (−0%) | $1,066.15 | $171K | +27.0% | — |
| Nov 21SEC | Lilly Endowment Inc10% Owner | Sell | 16,84592,627,607 held (−0%) | $1,050.36 | $17.7M | +28.9% | — |
| Nov 21SEC | Lilly Endowment Inc10% Owner | Sell | 6,70192,620,906 held (−0%) | $1,051.37 | $7.0M | +28.7% | — |
| Nov 21SEC | Lilly Endowment Inc10% Owner | Sell | 6,04792,614,859 held (−0%) | $1,052.55 | $6.4M | +28.6% | — |
| Nov 21SEC | Lilly Endowment Inc10% Owner | Sell | 3,70292,611,157 held (−0%) | $1,053.52 | $3.9M | +28.5% | — |
| Nov 21SEC | Lilly Endowment Inc10% Owner | Sell | 3,18892,607,969 held (−0%) | $1,054.51 | $3.4M | +28.4% | — |
| Nov 21SEC | Lilly Endowment Inc10% Owner | Sell | 66592,607,304 held (−0%) | $1,055.39 | $702K | +28.2% | — |
| Nov 20SEC | Lilly Endowment Inc10% Owner | Sell | 96,51692,715,462 held (−0%) | $1,050.21 | $101M | +28.9% | — |
| Nov 20SEC | Lilly Endowment Inc10% Owner | Sell | 28,76892,686,694 held (−0%) | $1,051.43 | $30.2M | +28.7% | — |
| Nov 20SEC | Lilly Endowment Inc10% Owner | Sell | 21,10792,665,587 held (−0%) | $1,052.54 | $22.2M | +28.6% | — |
| Nov 20SEC | Lilly Endowment Inc10% Owner | Sell | 13,82092,651,767 held (−0%) | $1,053.47 | $14.6M | +28.5% | — |
| Nov 20SEC | Lilly Endowment Inc10% Owner | Sell | 6,10992,645,658 held (−0%) | $1,054.48 | $6.4M | +28.4% | — |
| Nov 20SEC | Lilly Endowment Inc10% Owner | Sell | 1,20692,644,452 held (−0%) | $1,055.08 | $1.3M | +28.3% | — |
| Nov 19SEC | Lilly Endowment Inc10% Owner | Sell | 13,09792,827,399 held (−0%) | $1,035.50 | $13.6M | +30.7% | — |
| Nov 19SEC | Lilly Endowment Inc10% Owner | Sell | 12,19892,840,496 held (−0%) | $1,034.65 | $12.6M | +30.8% | — |
| Nov 19SEC | Lilly Endowment Inc10% Owner | Sell | 8,06792,819,332 held (−0%) | $1,036.58 | $8.4M | +30.6% | — |
| Nov 19SEC | Lilly Endowment Inc10% Owner | Sell | 7,20892,859,074 held (−0%) | $1,032.63 | $7.4M | +31.1% | — |
| Nov 19SEC | Lilly Endowment Inc10% Owner | Sell | 6,38092,852,694 held (−0%) | $1,033.50 | $6.6M | +31.0% | — |
| Nov 19SEC | Lilly Endowment Inc10% Owner | Sell | 4,30492,867,887 held (−0%) | $1,030.32 | $4.4M | +31.4% | — |
| Nov 19SEC | Lilly Endowment Inc10% Owner | Sell | 3,95092,812,958 held (−0%) | $1,038.48 | $4.1M | +30.3% | — |
| Nov 19SEC | Lilly Endowment Inc10% Owner | Sell | 2,42492,816,908 held (−0%) | $1,037.38 | $2.5M | +30.5% | — |
| Nov 19SEC | Lilly Endowment Inc10% Owner | Sell | 1,60592,866,282 held (−0%) | $1,031.41 | $1.7M | +31.2% | — |
| Nov 19SEC | Lilly Endowment Inc10% Owner | Sell | 98092,811,978 held (−0%) | $1,039.61 | $1.0M | +30.2% | — |
| Nov 18SEC | Lilly Endowment Inc10% Owner | Sell | 7,78992,874,288 held (−0%) | $1,030.45 | $8.0M | +31.4% | — |
| Nov 18SEC | Lilly Endowment Inc10% Owner | Sell | 2,09792,872,191 held (−0%) | $1,031.53 | $2.2M | +31.2% | — |
| Nov 17SEC | Lilly Endowment Inc10% Owner | Sell | 103,87192,956,501 held (−0%) | $1,030.31 | $107M | +31.4% | — |
| Nov 17SEC | Lilly Endowment Inc10% Owner | Sell | 55,90892,900,593 held (−0%) | $1,020.35 | $57.0M | +32.7% | — |
| Nov 17SEC | Lilly Endowment Inc10% Owner | Sell | 17,56792,883,026 held (−0%) | $1,020.35 | $17.9M | +32.7% | — |
| Nov 17SEC | Lilly Endowment Inc10% Owner | Sell | 94992,882,077 held (−0%) | $1,033.15 | $980K | +31.0% | — |
| Nov 14SEC | Lilly Endowment Inc10% Owner | Sell | 45,24693,061,732 held (−0%) | $1,030.21 | $46.6M | +31.4% | — |
| Nov 14SEC | Lilly Endowment Inc10% Owner | Sell | 1,36093,060,372 held (−0%) | $1,031.78 | $1.4M | +31.2% | — |
| Nov 13SEC | Lilly Endowment Inc10% Owner | Sell | 47,07393,116,934 held (−0%) | $1,018.02 | $47.9M | +33.0% | — |
| Nov 13SEC | Lilly Endowment Inc10% Owner | Sell | 23,86393,334,003 held (−0%) | $1,006.02 | $24.0M | +34.5% | — |
| Nov 13SEC | Lilly Endowment Inc10% Owner | Sell | 23,56893,357,866 held (−0%) | $1,004.97 | $23.7M | +34.7% | — |
| Nov 13SEC | Lilly Endowment Inc10% Owner | Sell | 22,13193,381,434 held (−0%) | $1,004.10 | $22.2M | +34.8% | — |
| Nov 13SEC | Lilly Endowment Inc10% Owner | Sell | 21,55993,229,271 held (−0%) | $1,011.96 | $21.8M | +33.8% | — |
| Nov 13SEC | Lilly Endowment Inc10% Owner | Sell | 20,00093,270,722 held (−0%) | $1,009.99 | $20.2M | +34.0% | — |
| Nov 13SEC | Lilly Endowment Inc10% Owner | Sell | 19,89293,250,830 held (−0%) | $1,011.18 | $20.1M | +33.9% | — |
| Nov 13SEC | Lilly Endowment Inc10% Owner | Sell | 17,98593,290,722 held (−0%) | $1,009.00 | $18.1M | +34.1% | — |
| Nov 13SEC | Lilly Endowment Inc10% Owner | Sell | 16,74993,212,522 held (−0%) | $1,012.94 | $17.0M | +33.6% | — |
| Nov 13SEC | Lilly Endowment Inc10% Owner | Sell | 16,27493,184,610 held (−0%) | $1,015.16 | $16.5M | +33.3% | — |
| Nov 13SEC | Lilly Endowment Inc10% Owner | Sell | 16,38393,317,620 held (−0%) | $1,007.10 | $16.5M | +34.4% | — |
| Nov 13SEC | Lilly Endowment Inc10% Owner | Sell | 13,41593,171,195 held (−0%) | $1,016.00 | $13.6M | +33.2% | — |
| Nov 13SEC | Lilly Endowment Inc10% Owner | Sell | 11,63893,200,884 held (−0%) | $1,014.17 | $11.8M | +33.5% | — |
| Nov 13SEC | Lilly Endowment Inc10% Owner | Sell | 8,91393,308,707 held (−0%) | $1,007.97 | $9.0M | +34.3% | — |
| Nov 13SEC | Lilly Endowment Inc10% Owner | Sell | 7,83393,109,101 held (−0%) | $1,018.83 | $8.0M | +32.8% | — |
| Nov 13SEC | Lilly Endowment Inc10% Owner | Sell | 7,58593,403,565 held (−0%) | $1,003.12 | $7.6M | +34.9% | — |
| Nov 13SEC | Lilly Endowment Inc10% Owner | Sell | 7,18893,164,007 held (−0%) | $1,017.16 | $7.3M | +33.1% | — |
| Nov 13SEC | Lilly Endowment Inc10% Owner | Sell | 1,28193,107,820 held (−0%) | $1,019.92 | $1.3M | +32.7% | — |
| Nov 13SEC | Donald A. ZakrowskiSvp, Finance, & Cao | Sell Plan | 1,0002,840 held (−26%) | $1,010.50 | $1.0M | +33.9% | — |
| Nov 13SEC | Lilly Endowment Inc10% Owner | Sell | 84293,106,978 held (−0%) | $1,021.07 | $860K | +32.6% | — |
| Nov 13SEC | Lilly Endowment Inc10% Owner | Sell | 82893,411,150 held (−0%) | $1,001.93 | $830K | +35.1% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 33,15493,497,965 held (−0%) | $990.19 | $32.8M | +36.7% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 30,63393,571,397 held (−0%) | $986.18 | $30.2M | +37.2% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 26,76193,471,204 held (−0%) | $991.01 | $26.5M | +36.6% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 22,12793,531,119 held (−0%) | $989.18 | $21.9M | +36.8% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 13,67893,557,719 held (−0%) | $987.18 | $13.5M | +37.1% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 12,86493,699,114 held (−0%) | $972.17 | $12.5M | +39.2% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 12,03993,430,231 held (−0%) | $996.38 | $12.0M | +35.8% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 11,99893,671,292 held (−0%) | $973.48 | $11.7M | +39.0% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 11,81993,683,290 held (−0%) | $972.27 | $11.5M | +39.2% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 11,06693,610,907 held (−0%) | $984.04 | $10.9M | +37.5% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 10,11493,661,178 held (−0%) | $974.47 | $9.9M | +38.9% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 9,87993,451,956 held (−0%) | $993.10 | $9.8M | +36.3% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 9,38793,420,844 held (−0%) | $997.06 | $9.4M | +35.8% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 9,36993,461,835 held (−0%) | $992.01 | $9.3M | +36.4% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 8,99693,652,182 held (−0%) | $975.46 | $8.8M | +38.8% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 8,87793,602,030 held (−0%) | $985.25 | $8.7M | +37.4% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 7,50393,621,973 held (−0%) | $983.14 | $7.4M | +37.7% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 5,75993,646,423 held (−0%) | $976.49 | $5.6M | +38.6% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 5,48293,415,362 held (−0%) | $998.29 | $5.5M | +35.6% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 5,02293,446,934 held (−0%) | $994.12 | $5.0M | +36.2% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 4,66493,442,270 held (−0%) | $995.25 | $4.6M | +36.0% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 4,68093,641,743 held (−0%) | $977.44 | $4.6M | +38.5% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 4,47393,553,246 held (−0%) | $987.91 | $4.4M | +37.0% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 4,43393,637,310 held (−0%) | $978.69 | $4.3M | +38.3% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 3,88793,695,227 held (−0%) | $973.63 | $3.8M | +39.0% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 3,55593,633,755 held (−0%) | $979.65 | $3.5M | +38.2% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 3,38493,411,978 held (−0%) | $999.09 | $3.4M | +35.5% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 2,21193,629,476 held (−0%) | $981.85 | $2.2M | +37.9% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 2,06893,631,687 held (−0%) | $980.54 | $2.0M | +38.0% | — |
| Nov 12SEC | Lilly Endowment Inc10% Owner | Sell | 11893,695,109 held (−0%) | $974.09 | $115K | +39.0% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 31,01693,888,897 held (−0%) | $925.87 | $28.7M | +46.2% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 15,23093,860,801 held (−0%) | $929.42 | $14.2M | +45.6% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 13,00793,756,183 held (−0%) | $945.62 | $12.3M | +43.1% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 12,92493,831,411 held (−0%) | $932.27 | $12.0M | +45.2% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 12,58193,769,190 held (−0%) | $944.68 | $11.9M | +43.3% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 10,93893,844,335 held (−0%) | $931.25 | $10.2M | +45.3% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 10,39293,717,787 held (−0%) | $952.89 | $9.9M | +42.0% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 10,20093,728,179 held (−0%) | $952.00 | $9.7M | +42.2% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 9,20993,815,560 held (−0%) | $934.21 | $8.6M | +44.9% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 8,40993,880,488 held (−0%) | $927.12 | $7.8M | +46.0% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 6,64293,824,769 held (−0%) | $933.29 | $6.2M | +45.0% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 6,38693,809,174 held (−0%) | $935.26 | $6.0M | +44.7% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 5,61793,744,884 held (−0%) | $948.82 | $5.3M | +42.7% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 5,52893,855,273 held (−0%) | $930.22 | $5.1M | +45.5% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 5,29293,803,882 held (−0%) | $936.57 | $5.0M | +44.5% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 4,69993,713,088 held (−0%) | $953.66 | $4.5M | +41.9% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 4,49593,740,389 held (−0%) | $949.82 | $4.3M | +42.5% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 4,45793,876,031 held (−0%) | $928.20 | $4.1M | +45.8% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 4,43493,923,098 held (−0%) | $922.42 | $4.1M | +46.7% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 3,96693,790,007 held (−0%) | $940.62 | $3.7M | +43.9% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 3,82093,781,771 held (−0%) | $943.71 | $3.6M | +43.4% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 3,77393,752,410 held (−0%) | $946.40 | $3.6M | +43.0% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 3,73193,800,151 held (−0%) | $937.42 | $3.5M | +44.4% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 3,38893,796,763 held (−0%) | $938.43 | $3.2M | +44.2% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 2,79093,793,973 held (−0%) | $939.54 | $2.6M | +44.1% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 2,75993,787,248 held (−0%) | $941.36 | $2.6M | +43.8% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 2,63593,920,463 held (−0%) | $923.46 | $2.4M | +46.6% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 2,09093,927,532 held (−0%) | $921.50 | $1.9M | +46.9% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 2,01093,738,379 held (−0%) | $950.94 | $1.9M | +42.3% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 1,90993,750,501 held (−0%) | $947.63 | $1.8M | +42.8% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 1,65793,785,591 held (−0%) | $942.31 | $1.6M | +43.6% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 1,11093,711,978 held (−0%) | $954.95 | $1.1M | +41.7% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 62093,930,562 held (−0%) | $913.78 | $567K | +48.1% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 55093,919,913 held (−0%) | $924.35 | $508K | +46.4% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 55093,930,012 held (−0%) | $915.33 | $503K | +47.9% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 27093,931,182 held (−0%) | $911.00 | $246K | +48.6% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 23093,929,782 held (−0%) | $917.26 | $211K | +47.6% | — |
| Nov 6SEC | Lilly Endowment Inc10% Owner | Sell | 16093,929,622 held (−0%) | $918.12 | $147K | +47.4% | — |
| Nov 5SEC | Lilly Endowment Inc10% Owner | Sell | 52693,931,452 held (−0%) | $910.72 | $479K | +48.6% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 29,70993,974,613 held (−0%) | $896.15 | $26.6M | +51.0% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 26,34094,122,873 held (−0%) | $884.66 | $23.3M | +53.0% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 25,99694,205,982 held (−0%) | $877.40 | $22.8M | +54.3% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 21,88494,100,989 held (−0%) | $885.56 | $19.4M | +52.8% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 19,29593,943,476 held (−0%) | $898.20 | $17.3M | +50.7% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 18,81594,187,167 held (−0%) | $878.36 | $16.5M | +54.1% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 17,63994,004,322 held (−0%) | $895.15 | $15.8M | +51.2% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 17,53794,021,961 held (−0%) | $894.33 | $15.7M | +51.3% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 17,29994,043,744 held (−0%) | $891.97 | $15.4M | +51.7% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 15,50894,061,043 held (−0%) | $891.17 | $13.8M | +51.9% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 14,86794,076,551 held (−0%) | $890.20 | $13.2M | +52.0% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 11,84293,962,771 held (−0%) | $897.20 | $10.6M | +50.9% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 10,68194,149,213 held (−0%) | $883.75 | $9.4M | +53.2% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 10,54994,170,493 held (−0%) | $880.45 | $9.3M | +53.7% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 6,37394,164,120 held (−0%) | $881.46 | $5.6M | +53.6% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 6,12594,181,042 held (−0%) | $879.36 | $5.4M | +53.9% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 5,39193,938,085 held (−0%) | $899.18 | $4.8M | +50.5% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 4,47493,933,611 held (−0%) | $900.02 | $4.0M | +50.4% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 4,24694,039,498 held (−0%) | $893.35 | $3.8M | +51.5% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 4,22694,159,894 held (−0%) | $882.32 | $3.7M | +53.4% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 4,08194,093,870 held (−0%) | $888.14 | $3.6M | +52.4% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 3,03894,097,951 held (−0%) | $886.29 | $2.7M | +52.7% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 2,45294,091,418 held (−0%) | $888.96 | $2.2M | +52.3% | — |
| Nov 4SEC | Lilly Endowment Inc10% Owner | Sell | 1,63393,931,978 held (−0%) | $900.79 | $1.5M | +50.3% | — |
| Nov 3SEC | Lilly Endowment Inc10% Owner | Sell | 197,81494,335,506 held (−0%) | $862.63 | $171M | +56.9% | — |
| Nov 3SEC | Lilly Endowment Inc10% Owner | Sell | 54,19194,281,315 held (−0%) | $863.42 | $46.8M | +56.8% | — |
| Nov 3SEC | Lilly Endowment Inc10% Owner | Sell | 15,67194,265,644 held (−0%) | $864.53 | $13.5M | +56.6% | — |
| Nov 3SEC | Lilly Endowment Inc10% Owner | Sell | 10,35894,244,930 held (−0%) | $866.55 | $9.0M | +56.2% | — |
| Nov 3SEC | Lilly Endowment Inc10% Owner | Sell | 10,35694,255,288 held (−0%) | $865.60 | $9.0M | +56.4% | — |
| Nov 3SEC | Lilly Endowment Inc10% Owner | Sell | 5,44094,234,888 held (−0%) | $868.44 | $4.7M | +55.9% | — |
| Nov 3SEC | Lilly Endowment Inc10% Owner | Sell | 4,60294,240,328 held (−0%) | $867.54 | $4.0M | +56.0% | — |
| Nov 3SEC | Lilly Endowment Inc10% Owner | Sell | 2,91094,231,978 held (−0%) | $869.47 | $2.5M | +55.7% | — |
| Oct 14SEC | Lilly Endowment Inc10% Owner | Sell | 3,19094,533,320 held (−0%) | $863.37 | $2.8M | +56.8% | — |
Similar past setups: not applicable. LLY has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with LLY in the Research Lab
LLY has no open-market insider buys in the last 12 months. Try the tools with any setup.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
Lilly (Eli) insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 5 sold $1.03B of LLY stock on the open market; P/E 43.9 vs. a sector median of 25.0.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
LLY insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $7.0M | 1 |
| Q3 2026 | — | 0 | $16.0M | 3 |
| Q2 2026 | — | 0 | $18.6M | 3 |
| Q1 2026 | — | 0 | $324M | 31 |
| Q4 2025 | — | 0 | $2.31B | 212 |
Valuation, profit and volume
Source: Yahoo Finance, as of Nov 19, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 0 Lilly (Eli) insiders reported open-market purchases totaling $0, while 5 insiders reported sales totaling $1.03B. 6 of 250 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
LLY earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Oct 29, 2026 | +10.3% | None | +10.0%S&P -2.1% | pending |
| Aug 5, 2026 | -2.7% | None | +6.8%S&P -0.4% | -3.4% |
| Apr 30, 2026 | -7.7% | None | +13.2%S&P +1.3% | +14.9% |
| Feb 4, 2026 | -3.4% | Sold $324M | +1.7%S&P -1.7% | -2.8% |
| Oct 30, 2025 | +0.1% | Sold $883M | +6.1%S&P -0.8% | +24.8% |
| Aug 7, 2025 | -3.9% | None | -16.2%S&P +0.7% | +16.5% |
| May 1, 2025 | +18.7% | None | -8.4%S&P +2.2% | -10.3% |
| Feb 6, 2025 | +13.4% | None | +4.3%S&P -0.6% | -0.8% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
LLY short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Members of Congress who traded LLY
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| John BoozmanSenate | Sold $1,001 - $15,000 | Nov 21, 2025 | Aug 24, 2026 | +28.3% |
| Thomas H TubervilleSenate | Sold $15,001 - $50,000 | Apr 15, 2025 | Aug 5, 2026 | +80.6% |
| Alan ArmstrongSenate | Sold $1,001 - $15,000 | Mar 27, 2026 | Jul 21, 2026 | +54.6% |
| Angus S King, Jr.Senate | Sold $1,001 - $15,000 | Feb 13, 2026 | Mar 24, 2026 | +30.6% |
| Angus S King, Jr.Senate | Bought $1,001 - $15,000 | Dec 29, 2025 | Jan 26, 2026 | +26.1% |
| Markwayne MullinSenate | Bought $15,001 - $50,000 | Dec 29, 2025 | Jan 16, 2026 | +26.1% |
| John BoozmanSenate | Sold $1,001 - $15,000 | Nov 21, 2025 | Dec 8, 2025 | +28.3% |
| Shelley M CapitoSenate | Bought $1,001 - $15,000 | Oct 24, 2025 | Nov 4, 2025 | +65.0% |
| John BoozmanSenate | Bought $1,001 - $15,000 | Aug 22, 2025 | Sep 12, 2025 | +91.4% |
| John BoozmanSenate | Bought $1,001 - $15,000 | Aug 11, 2025 | Sep 12, 2025 | +114.9% |
Insiders at Lilly (Eli)
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Lilly Endowment IncFormer 10% Shareholder | — | $3.53B | May 7, 2026 | — | — |
| Anat HakimEvp, Gc & Secretary | — | $13.0M | Nov 3, 2026 | — | — |
| Patrik JonssonPresident | — | $7.6M | Nov 10, 2026 | — | — |
| Donald A. ZakrowskiSvp, Finance, & Cao | — | $3.4M | Aug 11, 2026 | — | — |
| Ilya YuffaEvp&Pres, Lly Usa&Global Capab | — | $2.9M | Jun 11, 2026 | — | — |
| Carolyn R. BertozziDirector | — | — | Nov 17, 2026 | — | — |
| J. Erik FyrwaldDirector | — | — | Nov 17, 2026 | 0 of 2 | — |
| Juan R. LucianoDirector | — | — | Nov 17, 2026 | 1 of 1 | — |
| Kimberly H. JohnsonDirector | — | — | Nov 17, 2026 | — | — |
| Jon R. MoellerDirector | — | — | Nov 17, 2026 | — | — |
| Jamere JacksonDirector | — | — | Nov 17, 2026 | 1 of 1 | — |
| Gabrielle SulzbergerDirector | — | — | Nov 17, 2026 | — | — |
| Ralph AlvarezDirector | — | — | Nov 17, 2026 | — | — |
| Mary Lynne HedleyDirector | — | — | Nov 17, 2026 | — | — |
| Katherine BaickerDirector | — | — | Nov 17, 2026 | — | — |
| William G. Kaelin Jr.Director | — | — | Nov 17, 2026 | — | — |
| David A. RicksCEO, President | — | — | Nov 4, 2026 | 2 of 3 | — |
| Kenneth L. CusterPresident | — | — | Nov 3, 2026 | — | — |
| Edgardo HernandezEvp & Pres., Mfg. Operations | — | — | Nov 3, 2026 | — | — |
| Adrienne S. BrownPresident | — | — | Nov 3, 2026 | — | — |
| Eric DozierEvp, Chief People Officer | — | — | Nov 3, 2026 | — | — |
| Lucas MontarceCFO | — | — | Nov 3, 2026 | — | — |
| Daniel SkovronskyEvp, Cs&Po & Pres. Lrl | — | — | Nov 3, 2026 | — | — |
| Melissa SeymourEvp, Global Quality | — | — | Sep 11, 2026 | — | — |
| Diogo RauEvp & Cido | — | — | Feb 12, 2026 | — | — |
| Naarden Jacob VanEvp,Pres Lly Oncology&Hdcorpbd | — | — | Feb 11, 2026 | — | — |
Board links: companies that share insiders with LLY
Directors and executives who filed Form 4s for LLY and another company in the last 12 months.
- ADBEAdobe David A. Ricks CEO, President here · Director at ADBE · latest filing Nov 4, 2026
- ADMArcher Daniels Midland Juan R. Luciano Director here · CEO, President at ADM · latest filing Nov 17, 2026
- AZOAutoZone Jamere Jackson Director here · CFO at AZO · latest filing Nov 17, 2026
- IFFInternational Flavors & Fragrances J. Erik Fyrwald Director here · CEO at IFF · latest filing Nov 17, 2026
- ILMNIllumina Daniel Skovronsky Evp, Cs&Po & Pres. Lrl here · Director at ILMN · latest filing Nov 3, 2026
- MAMastercard Gabrielle Sulzberger Director here · Director at MA · latest filing Nov 17, 2026
- PGProcter & Gamble Jon R. Moeller Director here · Chair at PG · latest filing Nov 17, 2026
- TROWT. Rowe Price Kimberly H. Johnson Director here · COO at TROW · latest filing Nov 17, 2026
- VEEVVeeva Systems Mary Lynne Hedley Director here · Director at VEEV · latest filing Nov 17, 2026
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
LLY stock: common questions
Are Lilly (Eli) insiders buying LLY stock?
No. No Lilly (Eli) insider reported an open-market purchase of LLY in the past 12 months.
Are Lilly (Eli) insiders selling LLY stock?
5 insiders reported sales worth $1.03B over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is LLY's P/E ratio?
LLY trades at about 43.9 times trailing earnings, compared with a median of 25.0 for the Health Care sector.
What is LLY's 52-week range?
Over the past year LLY has traded between $848.53 and $1,443.50. It last closed at $1,353.51 on Nov 19, 2026.